Changes in expression of a microRNA showed potential for predicting response to the angiogenesis inhibitor bevacizumab (Avastin) in recurrent serous ovarian cancer, according to results of a small study reported here.
Most older patients with ovarian cancer may receive care that doesn't measure up to national standards, according to an analysis of a National Cancer Institute (NCI) database and Medicare claims data.
12/21/2010 Available ovarian cancer screening only slightly reduces the number of deaths from the disease, a new study finds. Until more sensitive screening tests can be developed, other strategies, such as better prevention and treatment, are needed to significantly reduce deaths from ovarian cancer, the researchers from Duke University Medical Center said. OCRF sponsored researcher, … Continued
11/08/2010 OCRF Grantee Lin Zhang, MD Research has provided strong support for the ovarian cancer stem cell hypothesis, which proposes that a rare subpopulation of tumor cells—cancer stem cells– have the unique ability to initiate and perpetuate tumor growth. The studies in Dr. Lin Zhang’s laboratory, which were supported by an OCRF Liz Tilberis award, have provided … Continued
09/28/2010 View a seven-part series about ovarian cancer, brought to you by the Ovarian Cancer Research Fund.The series is narrated by Douglas A. Levine, MD, of Memorial Sloan-Kettering Cancer Center. Dr. Levine is a member of OCRF’s Scientific Advisory Committee.The video also features OCRF Board Members Carmel Cohen, MD and Robin Zarel.
Some of you may have recently seen articles in the newspaper or on TV about a test called OVA1. OVA1 is a test approved by the FDA which measures the levels of five proteins in blood samples from women with a known ovarian mass that have been reported to change when ovarian cancer is present. … Continued
01/29/2010 Each year, OCRF awards millions of dollars in grants to researchers who are working to beat ovarian cancer. Our two newest grantees, Dr. Lin Zhang and Dr. Kathryn Terry, each received a $200,000 renewal, which will enable them to continue their work. Lin Zhang, MD Research Assistant Professor University of Pennsylvania School of Medicine … Continued
06/08/2009 Last weekend a European study regarding the use of CA 125 testing in ovarian cancer patients was presented at the American Society of Clinical Oncologists (ASCO) Annual Meeting. The study’s results indicate that women with relapsed ovarian cancer did not live longer if chemotherapy was started earlier based on a rising CA 125, as opposed to … Continued
03/17/2009 Today, the Ovarian Cancer Research Fund (OCRF) announced its most recent research grant recipients. Grants were awarded in three different categories: the Program Project Development Grant, the Liz Tilberis Award, and the Ovarian Cancer Research Training Program of Excellence. The grants, awarded to seventeen researchers at twelve research institutions, totaled over 5 million dollars. … Continued
On February 5, 2009, OCRF, in partnership with the Gynecologic Cancer Foundation (GCF), announced that Barbara Goff, M.D., Director of Gynecologic Oncology at the University of Washington, has been named to lead the OCRF Ovarian Cancer Symptoms Study. The award was presented by OCRF Scientific Advisory Board Vice-Chair, Carmel Cohen, M.D., at the Society of … Continued
Anil Sood, MD, Principal Investigator of the MD Anderson Cancer Center Program Project Development Grant, is featured in the December 17 Wall Street Journal article "Cancer Study Explores Role of 2 Proteins."
OCRF Partners with GCF to Continue Ovarian Cancer Symptoms Research Gynecologic Cancer Foundation Bulletin Summer 2008
Get email updates about research news, action alerts, and ways to join the fight.
